0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  March 01, 2013
Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia:  Specific Relevance of IgG NR1a Antibodies for Distinction From N -Methyl-D-Aspartate Glutamate Receptor Encephalitis
Johann Steiner, MD; Martin Walter, MD; Wenzel Glanz, MD; et al.
JAMA Psychiatry. 2013;70(3):271-278. doi:10.1001/2013.jamapsychiatry.86.
INCLUDES: , Supplemental Content
Original Article |  January 01, 2009 FREE
Childhood Trauma and Risk for Chronic Fatigue Syndrome:  Association With Neuroendocrine Dysfunction
Christine Heim, PhD; Urs M. Nater, PhD; Elizabeth Maloney, MS, DrPH; et al.
Arch Gen Psychiatry. 2009;66(1):72-80. doi:10.1001/archgenpsychiatry.2008.508.
Original Article |  May 01, 2008 FREE
Subsequent Risk of Hospitalization for Neuropsychiatric Disorders in Patients With Rheumatic Diseases:  A Nationwide Study From Sweden
Kristina Sundquist, MD, PhD; Xinjun Li, MD, PhD; Kari Hemminki, MD, PhD; et al.
Arch Gen Psychiatry. 2008;65(5):501-507. doi:10.1001/archpsyc.65.5.501.
Original Article |  December 01, 2006 FREE
Startle Gating Deficits in a Large Cohort of Patients With Schizophrenia:  Relationship to Medications, Symptoms, Neurocognition, and Level of Function
Neal R. Swerdlow, MD, PhD; Gregory A. Light, PhD; Kristin S. Cadenhead, MD; et al.
Arch Gen Psychiatry. 2006;63(12):1325-1335. doi:10.1001/archpsyc.63.12.1325.
Original Article |  November 01, 2006 FREE
Premorbid Predictors of Chronic Fatigue
Kenji Kato, PhD; Patrick F. Sullivan, MD, FRANZCP; Birgitta Evengård, MD, PhD; et al.
Arch Gen Psychiatry. 2006;63(11):1267-1272. doi:10.1001/archpsyc.63.11.1267.
Original Article |  November 01, 2006 FREE
Early Adverse Experience and Risk for Chronic Fatigue Syndrome:  Results From a Population-Based Study
Christine Heim, PhD; Dieter Wagner, PhD; Elizabeth Maloney, MS, DrPH; et al.
Arch Gen Psychiatry. 2006;63(11):1258-1266. doi:10.1001/archpsyc.63.11.1258.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Neurological Review  |  March 4, 2013
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis
Massimo Filippi, MD; Maria A. Rocca, MD; Mark A. Horsfield, PhD; et al.
JAMA Neurology
Viewpoint  |  March 4, 2013
The Gender Gap in Multiple Sclerosis:  Intersection of Science and Society
Shannon E. Dunn, PhD; Lawrence Steinman, MD
JAMA Neurology
Original Contribution  |  March 25, 2013
Microcystic Inner Nuclear Layer Abnormalities and Neuromyelitis Optica
Jeffrey M. Gelfand, MD; Bruce A. Cree, MD, PhD, MRC; Rachel Nolan, BA; et al.
JAMA Neurology
Correspondence  |  May 01, 2013
Interferon Beta and Long-term Disability in Multiple Sclerosis
Afsaneh Shirani, MD; Yinshan Zhao, PhD; Mohammad Ehsanul Karim, MSc; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems